Kidney cancer is a condition in which abnormal cells develop and multiply within the kidney. Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults.
Treatment depends on several factors, including the size and location of the kidney tumor, cancer stage, kidney function, overall health and whether the disease has spread to other parts of the body. Dr. Yash R. Godbole provides urological evaluation and individualized treatment planning for patients with kidney tumors and kidney cancer in Thane.
Kidney cancer develops when cells in the kidney grow abnormally and form a tumor. The kidneys are bean-shaped organs located on either side of the spine and are responsible for filtering waste products from the blood and producing urine.
Renal cell carcinoma is the most common kidney cancer in adults. Some kidney tumors may be detected incidentally during imaging performed for another medical condition, while others may cause symptoms as they grow.
Kidney tumors can be classified into different types. The type of tumor helps determine the appropriate diagnostic and treatment approach.
Renal cell carcinoma is the most common type of kidney cancer in adults. It includes different subtypes, with clear cell renal cell carcinoma being a common subtype.
Urothelial carcinoma can develop in the renal pelvis, the part of the urinary system where the kidney connects with the ureter.
Wilms tumor is a kidney cancer that primarily affects children and is uncommon in adults.
Other uncommon tumors can arise from different tissues within or around the kidney and may require specialized evaluation.
The exact cause of kidney cancer is not always known. Certain factors may increase the likelihood of developing kidney cancer.
Early kidney cancer may not cause any noticeable symptoms. When symptoms occur, they can vary depending on the size and location of the tumor and whether the disease has progressed.
Blood in the urine, known as hematuria, may appear pink, red or darker than usual and should be medically evaluated.
Persistent pain or discomfort in the side or lower back may occur in some patients.
A lump or mass in the abdomen may occasionally be noticed as a kidney tumor becomes larger.
Unintentional weight loss or reduced appetite may occur in some patients.
Persistent tiredness may occur and can sometimes be associated with anemia.
Unexplained or recurrent fever can occur in some patients and requires appropriate evaluation.
These symptoms do not necessarily mean that a person has kidney cancer. Several other urinary and medical conditions can produce similar symptoms. Persistent blood in urine, flank pain or other concerning symptoms should be evaluated by a doctor.
Diagnosis begins with a medical history and clinical examination, followed by appropriate imaging and laboratory investigations. The tests recommended depend on the suspected kidney abnormality and the patient's overall health.
Detailed imaging helps determine the size, location and characteristics of a kidney mass and can assist in assessing whether the tumor is confined to the kidney or has extended to nearby structures.
Staging determines how far kidney cancer has progressed. The TNM staging system considers the primary tumor, nearby lymph nodes and distant spread. Kidney cancer is commonly grouped into Stage I through Stage IV.
The tumor is limited to the kidney and is relatively small. Treatment may include partial or radical nephrectomy depending on the individual case.
The tumor is larger but remains confined to the kidney. Surgical treatment may be considered depending on the tumor and patient's clinical condition.
Cancer may have extended into nearby tissues, blood vessels or regional lymph nodes.
Cancer has extended beyond the kidney and surrounding tissues or has spread to distant organs.
A urological evaluation is important when a kidney mass is detected on imaging or when symptoms suggest a possible urinary or kidney abnormality.
Kidney cancer treatment is individualized. The appropriate approach depends on the tumor type, size, location, stage, kidney function, overall health and whether the cancer has spread.
Selected small kidney tumors may be monitored with regular imaging rather than treated immediately, particularly when immediate intervention may not be necessary.
The tumor and a margin of surrounding kidney tissue are removed while preserving as much healthy kidney tissue as possible.
The entire affected kidney is removed when partial nephrectomy is not appropriate or when the tumor characteristics require more extensive surgery.
Selected patients may be considered for techniques such as cryoablation or thermal ablation when surgical removal is not suitable.
Medicines that target specific pathways involved in cancer growth may be used for selected advanced kidney cancers.
Immunotherapy may be used in selected patients with advanced or metastatic kidney cancer as part of systemic treatment.
Surgery is an important treatment option for many patients with localized kidney cancer. The surgical approach is selected according to tumor size, location, complexity, kidney function and the overall clinical situation.
Partial nephrectomy removes the kidney tumor while preserving the remaining healthy kidney tissue when technically and oncologically appropriate.
Radical nephrectomy removes the entire affected kidney and may be recommended when the tumor cannot be safely or appropriately treated with partial nephrectomy.
Depending on the tumor and patient's condition, laparoscopic or robotic surgical techniques may be considered where appropriate and available.
The exact surgical technique depends on the tumor and the selected procedure. In general, surgery involves carefully planning access to the kidney, removing the tumor or affected kidney and sending the surgical specimen for pathological examination.
Imaging, blood tests, kidney function and other relevant investigations are reviewed before surgery.
The tumor size, location, relationship with blood vessels and surrounding structures are assessed to plan the procedure.
Kidney cancer surgery is generally performed under appropriate anesthesia with continuous monitoring.
Depending on the planned procedure, the surgeon removes the tumor while preserving healthy kidney tissue or removes the affected kidney.
The removed tissue is examined by a pathologist to confirm the diagnosis and provide information about the tumor.
Kidney function, pain, urine output and recovery are monitored following surgery.
Proper preparation helps the surgical team assess your health and plan the procedure safely.
Recovery depends on the type of surgery, the surgical approach, overall health and whether any complications occur.
Kidney function, urine output, pain, wound healing and other postoperative parameters are monitored.
Medicines may be prescribed to control postoperative discomfort during the initial recovery period.
Light activity is gradually increased according to the surgeon's instructions and individual recovery.
Follow-up visits and imaging may be recommended to monitor recovery and check for recurrence when appropriate.
Kidney function becomes particularly important after treatment, especially when part or all of one kidney has been removed. Long-term follow-up should be individualized according to the patient's kidney function, cancer characteristics and overall health.
Treatment can be selected according to tumor characteristics, cancer stage, kidney function and overall health.
Partial nephrectomy may preserve more healthy kidney tissue in appropriately selected patients.
Selected patients may be candidates for laparoscopic or robotic surgical approaches.
Follow-up helps monitor recovery, kidney function and possible recurrence according to the individual cancer risk.
The risks depend on the type of treatment, the extent of the tumor, the patient's health and the specific procedure performed.
After treatment, contact your treating team promptly if you develop high fever, severe or worsening pain, significant bleeding, difficulty passing urine, persistent vomiting, breathing difficulty or other concerning symptoms.
The expected outcome depends mainly on the type and stage of kidney cancer, tumor characteristics, whether the cancer has spread and the patient's overall health.
Localized kidney cancer may be treated with surgery in appropriate patients. Advanced disease may require systemic treatments such as immunotherapy or targeted therapy, sometimes combined with other approaches.
Regular follow-up after treatment is important to monitor kidney function, assess recovery and detect possible recurrence or new abnormalities at an appropriate stage.
The cost of kidney cancer treatment can vary significantly between patients because the treatment plan depends on the type and stage of cancer and the procedure required.
A personalized treatment estimate can be discussed after reviewing the patient's medical evaluation, imaging and treatment requirements.
Kidney cancer occurs when abnormal cells in the kidney grow uncontrollably and form a tumor. Renal cell carcinoma is the most common kidney cancer in adults.
Kidney cancer may cause blood in the urine, persistent flank pain, an abdominal mass, unexplained weight loss, fatigue or other symptoms. Early kidney cancer may not cause symptoms.
Diagnosis may involve physical examination, blood and urine tests and imaging such as ultrasound, CT or MRI. A biopsy may be recommended in selected cases.
Yes. In appropriately selected patients, partial nephrectomy can remove the tumor while preserving the remaining healthy kidney tissue.
Partial nephrectomy is a kidney-preserving operation in which the tumor and a small amount of surrounding tissue are removed while retaining the remaining kidney whenever appropriate.
Radical nephrectomy may be recommended when the tumor is not suitable for partial nephrectomy or when more extensive removal is required based on the tumor's characteristics.
Selected patients, particularly those with advanced or metastatic disease, may receive systemic treatments such as immunotherapy or targeted therapy.
The possibility of successful treatment depends on the cancer type, stage, tumor characteristics and individual health. Localized kidney cancer may be treated effectively with appropriate treatment.
Yes. Kidney cancer can recur after treatment, which is why individualized follow-up and surveillance are important.
Many people can live with one functioning kidney. Kidney function should continue to be monitored according to the treating doctor's recommendations.
You should consult a urologist if a kidney mass is detected on imaging, if you have unexplained blood in the urine or persistent flank pain, or if you require evaluation after previous kidney cancer treatment.
Dr. Yash R. Godbole is a Consultant Urologist & Andrologist providing evaluation and treatment planning for kidney and urinary tract conditions, including kidney tumors and kidney cancer.
Consult Dr. Yash R. Godbole for evaluation of a kidney tumor, kidney cancer diagnosis and discussion of appropriate treatment options based on your individual condition.
Medical Disclaimer: The information provided on this page is for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis or treatment. Kidney cancer treatment depends on the type, stage, tumor characteristics, kidney function and individual clinical findings. Please consult a qualified urologist or cancer care specialist for personalized medical advice.